Michael Thomas
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 61
- Oncology top 0.2%
- Lung Cancer Research Studies 101
- Colorectal Cancer Treatments and Studies 40
- Cancer Immunotherapy and Biomarkers 36
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 195
- Lung Cancer Diagnosis and Treatment 88
- Molecular Biology top 1%
-
- Palliative Care and End-of-Life Issues 28
-
- Neuroendocrine Tumor Research Advances 24
Michael Thomas
342 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 3.5k
- Oncology 5.9k
- Pulmonary and Respiratory Medicine 6.6k
- Molecular Biology 4.0k
- Radiology, Nuclear Medicine and Imaging 1.1k
Countries citing papers authored by Michael Thomas
This map shows the geographic impact of Michael Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Thomas more than expected).
Fields of papers citing papers by Michael Thomas
This network shows the impact of papers produced by Michael Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Thomas. The network helps show where Michael Thomas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 23 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 17 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 43 | |
| 15 | 2018 | 117 | |
| 16 | 2015 | 45 | |
| 17 | 2015 | 29 | |
| 18 | 2014 | 18 | |
| 19 | The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survivalbreakdown → | 2012 | 542 |
| 20 | 2004 | 168 |
About Michael Thomas
Michael Thomas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 359 papers that have together received 12.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (195 papers), Lung Cancer Research Studies (101 papers), Lung Cancer Diagnosis and Treatment (88 papers), Cancer Genomics and Diagnostics (61 papers), Colorectal Cancer Treatments and Studies (40 papers), Cancer Immunotherapy and Biomarkers (36 papers), Palliative Care and End-of-Life Issues (28 papers) and Neuroendocrine Tumor Research Advances (24 papers). The work is most often cited by research in Cancer Research (3.5k citations), Oncology (5.9k citations) and Pulmonary and Respiratory Medicine (6.6k citations). Michael Thomas has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Wolfgang E. Berdel, Carsten Müller‐Tidow, Hubert Serve, Sven Diederichs, Thomas Muley, Paul M. Schneider, Burkhard Brandt, Etmar Bulk, Ralf Metzger and Ping Ji. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, Journal of Thoracic Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.